HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
0.9900
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST
HST Global Market Cap
HST Global has a market cap or net worth of $139.7 million as of February 13, 2026. Its market cap has increased by 31,213.62% in one year.
Market Cap
139.70M
Enterprise Value
140.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.99
Market Cap Chart
Since May 12, 2008, HST Global's market cap has increased from 11.89M to 139.70M, an increase of 1,075.35%. That is a compound annual growth rate of 14.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 139.70M | 6.06% |
| Dec 9, 2025 | 131.71M | 224.37% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 305.90M |
| Silence Therapeutics | 204.52M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |